联系方式：400-650-8506
CNEN
产品名称 TAK 438
产品货号 Axon 1971 CAS [881681-01-2] MF C17H16FN3O2S.C4H4O4MW 461.46 Purity: 98% Soluble in DMSO Description Potassium-competitive acid blocker (P-CAB); reversibly inhibits gastric H+, K+-ATPase; TAK-438 exerts a longer and more potent antisecretory effect than lansoprazole as a result of its high accumulation and slow clearance from the gastric glands References Certificates Categories Extra info J Matsukawa et al. A comparative study on the modes of action of TAK-438, a novel potassium-competitive acid blocker, and lansoprazole in primary cultured rabbit gastric glands. Biochem. Pharmacol. 2011, 81(9), 1145-1151.    JM Shin et al. Characterization of a novel potassium-competitive acid blocker of the gastric H,K-ATPase, 1-[5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine (...). J. Pharmacol. Exp. Ther. 2011, 339(2), 412-420.  Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Diabetes & Metabolism ATPase (H+K+) EC 3.6.3.10 Potassium-competitive acid blocker (P-CAB) Chemical name 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate Parent CAS No. [881681-00-1] Order Size Unit Price Stock 5 mg €145.00 In Stock
产品价格 现货询价，电话：010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

TAK 438

Based on 15 reference(s) in Google Scholar 8 10 15

Axon 1971

CAS [881681-01-2]

MF C17H16FN3O2S.C4H4O4
MW 461.46

  • Purity: 98%
  • Soluble in DMSO

TAK 438

Description

Potassium-competitive acid blocker (P-CAB); reversibly inhibits gastric H+, K+-ATPase; TAK-438 exerts a longer and more potent antisecretory effect than lansoprazole as a result of its high accumulation and slow clearance from the gastric glands
产品资料